Damasco-Gutier Daisy MD - 91910 Chula Vista, CA

Business Name: Damasco-Gutier Daisy MD
Categorized In: Doctors
Address: 386 East H St # 210, Chula Vista, CA 91910
Phone Number: (619) 427-5053
Contact Person: Daisy Damasco-Gutier,
Website Address: drmonahan.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Szkopiec Roman L MD - Chula Vista, CA 91910
Mafong Erick A MD - Chula Vista, CA 91910
Hudler Elizabeth MD - Chula Vista, CA 91910
Children's Medical Group-S Bay - Chula Vista, CA 91910
Gutierrez Daisy C MD - Chula Vista, CA 91910
Monahan David E MD - Chula Vista, CA 91910
Farris Reuben M MD - Chula Vista, CA 91910
Cepin Monica MD - Chula Vista, CA 91910
Juarez-Uribe Joel MD - Chula Vista, CA 91910
Delgnan William MD - Chula Vista, CA 91910
Mohler Christy MD - Chula Vista, CA 91910
Sadeghi Mehrdad MD - Chula Vista, CA 91910
Madany George MD - Chula Vista, CA 91910
Waisman Norberto MD - Chula Vista, CA 91910
Violeta Curbelo Md - Chula Vista, CA 91910
Raeber Kirk J DO - Chula Vista, CA 91910
Garay Alan MD - Chula Vista, CA 91910
Otten Richard MD - Chula Vista, CA 91910
Jankiewicz Joseph MD - Chula Vista, CA 91910
Montoya Perry V MD - Chula Vista, CA 91910

Damasco-Gutier Daisy MD provides professional Doctors from its single location at the coordinates 32.64004,-117.0484.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 386 East H St # 210, Chula Vista, California 91910 or contacted through representative Daisy Damasco-Gutier, at (619) 427-5053.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Damasco-Gutier Daisy MD through its company website at drmonahan.com. Engage with this business on its social media platforms through on Twitter and on Facebook.